Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance  COVID-19 status Phase of research How it helps Latest publication
Leporin A
Potential treatment - theoretical effect Natural product Antiviral Dec/02/2020
Leucopelargonidin
Potential treatment - theoretical effect Natural product Antiviral Sep/18/2020
Levan N
Potential treatment - theoretical effect Natural product Antiviral Feb/15/2021
Lianhua Qingwen
Recommended by China's NHC Guidelines Natural product Other treatment Jan/29/2021
Limonin
Potential treatment - theoretical effect Natural product Antiviral Aug/07/2020
Linolenic acid
Potential treatment - pre-clinical evidence Natural product Antiviral Mar/04/2021
Liquiritin
Potential treatment - pre-clinical evidence Natural product Antiviral May/02/2020
Lupinifolin
Potential treatment - theoretical effect Natural product Antiviral Oct/21/2020
Luteolin
Potential treatment - theoretical effect Natural product Antiviral Feb/24/2021
Lycorine
Potential treatment - pre-clinical evidence Natural product Antiviral Dec/16/2020
Mahuang Liu Jun Tang
Potential treatment - clinical evidence Natural product Unknown Sep/14/2020
Masoprocol
Potential treatment - theoretical effect Natural product Antiviral Feb/24/2021
Melatonin
Potential treatment - theoretical effect Natural product Antiviral Nov/06/2020
Mentha haplocalyx extract
Potential treatment - pre-clinical evidence Natural product Antiviral Jan/15/2021
Methyl allyl disulfide
Potential treatment - theoretical effect Natural product Antiviral Mar/31/2020
Mezerein
Potential treatment - theoretical effect Natural product Antiviral Mar/23/2021
MIR2911
Potential treatment - clinical evidence Natural product Antiviral Aug/05/2020
mmu-miR-200c
Potential treatment - theoretical effect Natural product Other treatment Sep/03/2020
Morin
Potential treatment - theoretical effect Natural product Antiviral Feb/01/2021
Myricetin
Potential treatment - pre-clinical evidence Natural product Antiviral Jan/04/2021